GNI GroupGNI Group Ltd.2160東証グロース医薬品FY ending Dec 2024, consolidated, IFRS
Out of every ¥100 of sales, about ¥6 is left as operating profit. Revenue changed -9.2% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | -1.2% | —× | — |
| 2021 | — | —× | 3.5% | —× | — |
| 2022 | — | —× | 1.2% | —× | — |
| 2023 | 31.1% | 0.53× | 16.5% | 1.34× | 22.2% |
| 2024 | 4.7% | 0.35× | 1.6% | 1.87× | 3.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Dec 2018 | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 |
|---|---|---|---|---|---|
| Revenue | 5,019 | 12,690 | 17,418 | 26,010 | 23,611 |
| Cost of revenue | — | — | — | — | 5,574 |
| Gross profit | — | — | — | — | 18,037 |
| SG&A | — | — | — | — | 15,771 |
| Operating income | — | — | — | — | 1,402 |
| Pretax income | 365 | 1,107 | 767 | 12,612 | 238 |
| Income tax | — | — | — | — | 247 |
| Net income attributable to owners | -200 | 1,066 | 388 | 8,094 | 1,098 |
| Operating margin | — | — | — | — | 5.9% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Dec 2018 | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥4.87B | ¥14.4B | ¥11B | ¥21.6B | ¥10.1B |
| Total assets | ¥17.1B | ¥30.3B | ¥33.9B | ¥64.3B | ¥71.9B |
| Net assets | ¥10B | — | — | ¥36.5B | ¥39.7B |
| Share capital | — | — | — | — | ¥13.3B |
| Property, plant and equipment | — | — | — | — | ¥5.7B |
| Goodwill | — | — | — | — | ¥16B |
| Current assets | — | — | — | — | ¥29.2B |
| Total liabilities | — | — | — | — | ¥32.2B |
| Equity attributable to owners of parent | — | — | — | — | ¥36.4B |
| Retained earnings | — | — | — | — | ¥9.89B |
| Treasury stock | — | — | — | — | -¥15M |
EDINET (FSA Japan)
有価証券報告書－第25期(2025/01/01－2025/12/31)
EDINET (FSA Japan)
有価証券報告書－第24期(2024/01/01－2024/12/31)
EDINET (FSA Japan)
有価証券報告書－第22期(2022/01/01－2022/12/31)
EDINET (FSA Japan)
訂正有価証券報告書－第21期(令和3年1月1日－令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書－第20期(令和2年1月1日－令和2年12月31日)
Extracted from XBRL: 42 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.